Literature DB >> 28867478

Hemidesmosomal linker proteins regulate cell motility, invasion and tumorigenicity in oral squamous cell carcinoma derived cells.

Pratik Rajeev Chaudhari1, Silvania Emlit Charles2, Zinia Charlotte D'Souza2, Milind Murlidhar Vaidya3.   

Abstract

BPAG1e and Plectin are hemidesmosomal linker proteins which anchor intermediate filament proteins to the cell surface through β4 integrin. Recent reports indicate that these proteins play a role in various cellular processes apart from their known anchoring function. However, the available literature is inconsistent. Further, the previous study from our laboratory suggested that Keratin8/18 pair promotes cell motility and tumor progression by deregulating β4 integrin signaling in oral squamous cell carcinoma (OSCC) derived cells. Based on these findings, we hypothesized that linker proteins may have a role in neoplastic progression of OSCC. Downregulation of hemidesmosomal linker proteins in OSCC derived cells resulted in reduced cell migration accompanied by alterations in actin organization. Further, decreased MMP9 activity led to reduced cell invasion in linker proteins knockdown cells. Moreover, loss of these proteins resulted in reduced tumorigenic potential. SWATH analysis demonstrated upregulation of N-Myc downstream regulated gene 1 (NDRG1) in linker proteins downregulated cells as compared to vector control cells. Further, the defects in phenotype upon linker proteins ablation were rescued upon loss of NDRG1 in linker proteins knockdown background. These data together indicate that hemidesmosomal linker proteins regulate cell motility, invasion and tumorigenicity possibly through NDRG1 in OSCC derived cells.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BPAG1e; Cell invasion; Cell motility; NDRG1; Oral squamous cell carcinoma; Plectin

Mesh:

Substances:

Year:  2017        PMID: 28867478     DOI: 10.1016/j.yexcr.2017.08.034

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells.

Authors:  Satya Prakash Shukla; Aaron Raymond; Vineeta Rustagi; Samanth R Kedika; Olivia Tran; Liye Wang; Bin Guo; D Gomika Udugamasooriya
Journal:  Bioorg Chem       Date:  2021-09-08       Impact factor: 5.275

2.  Transcriptional Biomarkers in Oral Cancer: An Integrative Analysis and the Cancer Genome Atlas Validation.

Authors:  Kinjal D Patel; Hemangini H Vora; Prabhudas S Patel
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

3.  Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method.

Authors:  Mythreyi Narasimhan; Sadhana Kannan; Aakash Chawade; Atanu Bhattacharjee; Rukmini Govekar
Journal:  J Transl Med       Date:  2019-05-31       Impact factor: 5.531

Review 4.  Plectin in Cancer: From Biomarker to Therapeutic Target.

Authors:  Samantha M Perez; Lindsey T Brinton; Kimberly A Kelly
Journal:  Cells       Date:  2021-08-30       Impact factor: 6.600

5.  Disassembly of α6β4-mediated hemidesmosomal adhesions promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin to focal adhesions.

Authors:  Tomasz Wenta; Anette Schmidt; Qin Zhang; Raman Devarajan; Prateek Singh; Xiayun Yang; Anne Ahtikoski; Markku Vaarala; Gong-Hong Wei; Aki Manninen
Journal:  Oncogene       Date:  2022-07-01       Impact factor: 8.756

6.  Collagen XVII inhibits breast cancer cell proliferation and growth through deactivation of the AKT/mTOR signaling pathway.

Authors:  Muttarin Lothong; Watchara Sakares; Pornchai Rojsitthisak; Chizu Tanikawa; Koichi Matsuda; Varalee Yodsurang
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

Review 7.  Mammalian Plakins, Giant Cytolinkers: Versatile Biological Functions and Roles in Cancer.

Authors:  Lifang Hu; Zizhan Huang; Zixiang Wu; Arshad Ali; Airong Qian
Journal:  Int J Mol Sci       Date:  2018-03-24       Impact factor: 5.923

8.  The spectraplakin Dystonin antagonizes YAP activity and suppresses tumourigenesis.

Authors:  Praachi B Jain; Patrícia S Guerreiro; Sara Canato; Florence Janody
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.